The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.715
Bid: 0.65
Ask: 0.70
Change: 0.09 (14.40%)
Spread: 0.05 (7.692%)
Open: 0.625
High: 0.715
Low: 0.715
Prev. Close: 0.625
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment

22 Mar 2016 16:14

RNS Number : 9481S
Onzima Ventures PLC
22 March 2016
 

22 March 2016

 

Onzima Ventures PLC

 

("Onzima" or the "Company")

 

Investment

 

The Company announces that it has participated in the placing of new ordinary shares by Jubilee Platinum plc ("Jubilee") as announced today as part of a total fundraise of £2.5 million gross.

 

Jubilee has also today announced the successful completion of debt project funding for the execution and commissioning of both of its two surface platinum processing projects at Dilokong and Hernic in South Africa. The debt funding comprises a combination of senior secured debt to a maximum of USD 10 million (ZAR 153 million) and unsecured debt to a maximum of USD 5 million (ZAR 76.5 million). The total funding allows Jubilee to execute simultaneously its two projects targeting the processing of 80,000 tonnes per month of surface material, while still being able to pursue the acquisition or securing of further surface or shallow platinum bearing opportunities.

 

Onzima subscribed for 4.7million shares at 2.8p per share for a total sum of approximately £132,000.

 

Luke Cairns, Director of Onzima, stated: "We are pleased to have taken part in this fundraising at what we consider is an attractive price. Jubilee is at a transformational stage as it looks to move into production at both of its new platinum tailings operations, while its Tjate mine project progresses in the background. Jubilee expects both Dilokong and Hernic to be producing this year thus we anticipate plenty of positive newsflow in the short term."

 

 

For further information please contact:

 

Onzima Ventures PLC Tel: +44 (0) 1732 366561

Gavin Burnell, Luke Cairns

 

Nominated Adviser

Cairn Financial Advisers LLP Tel: +44 (0) 20 7148 7900

Sandy Jamieson, Liam Murray

 

Broker

Peterhouse Corporate Finance Limited Tel: +44 (0) 20 7469 0930

Guy Miller, Lucy Williams

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKDAAFDKEFF
Date   Source Headline
11th Nov 20202:05 pmRNSSecond Price Monitoring Extn
11th Nov 20202:00 pmRNSPrice Monitoring Extension
11th Nov 202011:05 amRNSSecond Price Monitoring Extn
11th Nov 202011:00 amRNSPrice Monitoring Extension
9th Nov 20207:00 amRNSLaunch of Nuvec® Oncology Treatment Programme
5th Nov 20207:00 amRNSOperational Update
30th Sep 20207:00 amRNSTotal Voting Rights
17th Sep 20207:00 amRNSInterim Results
15th Sep 20202:06 pmRNSSecond Price Monitoring Extn
15th Sep 20202:01 pmRNSPrice Monitoring Extension
14th Sep 202011:05 amRNSSecond Price Monitoring Extn
14th Sep 202011:00 amRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSCovid-19 Proof of Concept Update
8th Sep 202011:40 amRNSExercise of Options
2nd Sep 20208:00 amRNSHolding(s) in Company
2nd Sep 20208:00 amRNSTotal Voting Rights
1st Sep 20207:00 amRNSTechnology Transfer and Manufacturing Contract
26th Aug 20203:47 pmRNSExercise of Warrants and Issue of Equity
14th Aug 20202:22 pmRNSExercise of Warrants and Issue of Equity
14th Aug 202011:06 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
12th Aug 20202:00 pmRNSPrice Monitoring Extension
12th Aug 20201:47 pmRNSPositive Covid-19 In Vitro Study Results
27th Jul 202011:05 amRNSSecond Price Monitoring Extn
27th Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 202011:00 amRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSChange of Adviser
6th Jul 20207:00 amRNSWork Programme and Strategic Update
18th Jun 202012:05 pmRNSResult of General Meeting and grant of warrants
1st Jun 202012:28 pmRNSPosting of circular and notice of general meeting
29th May 20205:00 pmRNSTotal Voting Rights
28th May 20209:00 amRNSPrice Monitoring Extension
28th May 20207:00 amRNSCovid-19 Project Update
21st May 20204:26 pmRNSHolding(s) in Company
20th May 202012:29 pmRNSHolding(s) in Company
18th May 20204:41 pmRNSSecond Price Monitoring Extn
18th May 20204:37 pmRNSPrice Monitoring Extension
18th May 20204:29 pmRNSGrant of Options
18th May 20202:25 pmRNSPatent filing update
13th May 20201:58 pmRNSPlacing to raise £2m & appointment of Joint Broker
24th Apr 20207:00 amRNSNew Nuvec® opportunity and patent filing
23rd Apr 202011:01 amRNSResult of AGM
17th Apr 20207:00 amRNSAttendance at the Company's annual general meeting
16th Apr 20207:00 amRNSCovid-19 Project Update
15th Apr 20209:05 amRNSSecond Price Monitoring Extn
15th Apr 20209:00 amRNSPrice Monitoring Extension
30th Mar 20202:05 pmRNSSecond Price Monitoring Extn
30th Mar 20202:00 pmRNSPrice Monitoring Extension
25th Mar 20201:18 pmRNSChanges to AGM
25th Mar 20207:00 amRNSCovid-19 Project Update and operational update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.